JucaBio
Cincinnati, US · Founded 2023 · Delaware LLC · 15 employees on LinkedIn
Find your way into JucaBio
200 people in our graph share verified history with the JucaBio team — schools, employers, funds. One of them is your warm intro.
JucaBio is a privately held, clinical-stage biopharmaceutical company using a hub-and-spoke model to acquire differentiated drug assets and build subsidiaries that run focused clinical development programs. It targets drugs addressing significant unmet medical needs.
Founders & leadership
JucaBio was founded in 2023 by Justin R Thompson.


Funding
SEC filings, press & company announcements$3.8M disclosed across 1 of 2 rounds · 2024–2025
- Undisclosed amountSeries ASep 2025Source ↗
▶$3.8MraisedJan 2025 · 10 investors · OtherRule 506(b)
- Justin ThompsonExecutive Officer, Director
- Catherine PearceExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $3.8M
- First sale
- Dec 2024
- Incorporated
- Limited Liability Company, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with JucaBio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does JucaBio do?
- JucaBio is a privately held, clinical-stage biopharmaceutical company using a hub-and-spoke model to acquire differentiated drug assets and build subsidiaries that run focused clinical development programs. It targets drugs addressing significant unmet medical needs.
- Who founded JucaBio?
- JucaBio was founded by Justin R Thompson in 2023.
- How much funding has JucaBio raised?
- JucaBio has disclosed $3.8M raised across 1 of its 2 known rounds.
- Where is JucaBio headquartered?
- JucaBio is headquartered in Cincinnati, US.

.webp)

